Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

LOPERAMIDE HCL

All products: Limited Use (codes 110, 111, 112, 113, 114, 115, 224)

Other products in the same Health Canada class (A07DA) — coverage varies; not interchangeable

  • Atropine + diphenoxylate (Lomotil): limited Use 110, 111, 112, 113, 114, 115, 224

Teva-Loperamide · DIN 02132591 · 2mg · Caplet

Limited Use — Reason for Use code 110, 111, 112, 113, 114, 115, 224 requiredMarketed · checked 2026-09-02
StatusLimited Use — Reason for Use code 110, 111, 112, 113, 114, 115, 224 required
Write on scriptLU code 110, 111, 112, 113, 114, 115, 224 (patient must meet the criteria below)
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
Ontario Limited Use criteria — code 110, 111, 112, 113, 114, 115, 224
Coverage limit: For the treatment of diarrhea associated with: Reason for Use code 110 An ileostomy or a colostomy;. Coverage limit: LU Authorization Period: 1 year Reason for Use code 111 Bowel resection, including short bowel syndrome; Coverage limit: LU Authorization Period: 1 year Reason for Use code 112 Inflammatory Bowel Diseases, i.e. Crohn's Disease and Ulcerative Colitis; Coverage limit: LU Authorization Period: 1 year Reason for Use code 113 Cancer, including chemotherapy or radiation therapy; Coverage limit: LU Authorization Period: 1 year Reason for Use code 114 HIV/AIDS; Coverage limit: LU Authorization Period: 1 year Reason for Use code 115 Acute diarrhea in patients in congregated housing, i.e. Long Term Care Facilities (LTCF), or for patients receiving Home Care; Coverage limit: LU Authorization Period: 1 year Reason for Use code 224 Fecal incontinence. Coverage limit: LU Authorization Period: 1 year
1 brand, same coverage
Teva-Loperamide · DIN 02132591 Manufacturer: Teva Canada Limited; listing date 1997-08-28 Health Canada: Marketed since 2016-12-23 · brand TEVA-LOPERAMIDE · ATC A07DA03 LOPERAMIDE · form Tablet · route Oral · ingredients LOPERAMIDE HYDROCHLORIDE 2 MG · company Teva canada limited · schedule Non-prescription drugs
Check this DIN again · Health Canada product record

Teva-Loperamide: Formulary list price $0.0952/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0952 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18071 · Verify on the e-Formulary ↗ (DIN 02132591)

Source record
DIN 02132591: Teva-Loperamide Raw flags: sec12=Y, sec3=Y Item: 560800015; group id 647; item number 1626; lccId 00096; manufacturer id TEV Source form: Caplet; strength: 2mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below Source prices (unrounded): $0.0952; ministry $0.0952 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02132591 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18071
Interchangeable products
Apo-Loperamide · DIN 02212005 · $0.0952 Imodium · DIN 00860743 · not recorded PMS-Loperamide · DIN 02228351 · $0.0952
Shortage status: resolved shortage (ended 2023-07-20); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02132591
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Other drugs in the same formulary class (56:08 Antidiarrhea Agents) and how they are covered

Matched class: 56:08 Antidiarrhea Agents

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. No displayed product is listed as a general benefit in this extract. Check its listing requirements below. 56:08 Antidiarrhea Agents

DIPHENOXYLATE HYDROCHLORIDE & ATROPINE SULFATE

· 1 products · Limited Use, codes 110, 111, 112, 113, 114, 115, 224 · strengths: 2.5mg & 0.025mg · Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 56:08
Full class listing Related classes: 56:04 Antacids and Adsorbents, 56:12 Cathartics, 56:16 Digestants, 56:22 Antiemetics and Antinauseants, 56:40 Miscellaneous G.I. Drugs Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
1 INDICATIONS TEVA-LOPERAMIDE (Loperamide Hydrochloride) is indicated:  as an adjunct to rehydration therapy for the symptomatic control of acute non-specific diarrhea  for chronic diarrhea associated with inflammatory bowel disease  for reducing the volume of discharge for ileostomies, colostomies and other intestinal resections Treatment of diarrhea with TEVA-LOPERAMIDE is only symptomatic. Whenever an underlying etiology can be determined, specific treatment should be given when appropriate (or when indicated). 1.1 Pediatrics Pediatrics (2 to 12 years of age): Loperamide should be used in children only on the advice of a physician. TEVA-LOPERAMIDE tablets are not suited for children under 6 years of age. 1.2 Geriatrics Geriatrics (>65 years of age): No dose adjustments are required for the elderly. https://pdf.hres.ca/dpd_pm/00080964.PDF PM date: December 23, 2016 Source product: TEVA-LOPERAMIDE; DIN 02132591; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.